Call for Papers (Deadline Extended): The International eHealth, Telemedicine and Health ICT Forum

14-16 April 2010, Luxembourg.
Join Med-e-Tel 2010 and actively participate in the educational and information program of seminars, demonstrations and interactive panel discussions on eHealth, telemedicine and ICT applications in medicine and healthcare. Supported by a wide range of national and international associations and institutions, this three day meeting and networking event brings together stakeholders and leading experts from around the world to present and share recent achievements and developments in the field. Med-e-Tel is also accredited to give up to 18 hours of CME (Continuing Medical Education) for medical professionals.

The areas covered include (but are not strictly limited to):

  • Bio-informatics and bio-medical technologies
  • Cost-benefit studies
  • Disease management and patient compliance
  • eHealth and telemedicine implementation in low resource settings
  • eHealth integration into routine medical practice
  • eHealth master plan development for developing countries
  • Elderly care, services for the ageing
  • eLearning, distance education
  • Electronic health records, personal health records
  • ePrescription
  • Facilitating collaboration among existing projects and applications
  • Health and wellness promotion
  • Legal and ethical aspects
  • Market trends
  • Mobile/wireless healthcare
  • Opportunities for and barriers to eHealth and telemedicine implementation
  • Reimbursement issues
  • Remote patient monitoring, homecare applications
  • Secure data transmission, privacy issues
  • Smart homes and independent living
  • Standardization and interoperability
  • Strategies for the future
  • Telemedicine applications in cardiology, dermatology, radiology, wound care, and other medical disciplines
  • Telenursing and nursing informatics
  • Telepaediatrics
  • Telepsychology, telepsychiatry
  • Telerehabilitation, cybertherapy
  • etc.

Presentation proposals on the above and other relevant topics for inclusion into the Med-e-Tel conference program are welcome. In special are encouraged contributions on practical experiences, business cases, projects, pilots, and research activities. Through the presentations, the expo and the extensive networking opportunities, attendees will have unmatched possibilities to gather the latest news from leaders in the field and to establish new professional relationships.

Abstract submission
Click here for the online abstract submission form and follow the guidelines (note in advance: text of the abstract should be limited to max. 3500 characters). All abstracts should be submitted using this online form. Abstract submission deadline is 31 December 2009 15 January 2010.

Important dates

  • 1 September 2009 - Call for Abstracts opens
  • 31 December 2009 15 January 2010 - Abstract submission deadline
  • 15 January 2010 22 January 2010 - Notification of acceptance
  • 8 February 2010 - Deadline for camera-ready submission of full text papers
  • 31 March 2010 - Deadline for submitting PowerPoint presentations
  • 14-16 April 2010 - Med-e-Tel 2010

For questions regarding the submission of abstracts and the educational program, please feel free to contact Dr. Malina Jordanova, Educational Program Coordinator, tel/fax: +359 2 979 70 80, or e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.

For general information regarding Med-e-Tel and sponsorship/exhibition opportunities, please contact Frederic Lievens, International Coordinator, tel: +32 2 269 84 56, fax: +32 2 269 79 53, or e-mail This email address is being protected from spambots. You need JavaScript enabled to view it..

For further information and registration, please visit:
http://www.medetel.eu

About Med-e-Tel
Med-e-Tel focuses on ehealth and telemedicine applications and a wide range of other medical ICT applications and on the convergence of information and communication technology with medical applications, which lead to higher quality of care, cost reductions, workflow efficiency, and widespread availability of healthcare services.

The "Med" in Med-e-Tel stands for healthcare services (institutional and home based care, prevention and education) and for medical products and equipment (medical imaging equipment, monitoring devices, electronic health records, etc.).
The "e" stands for the electronic and IT industry and services (hard- & software, internet, e-mail, etc.).
The "Tel" stands for telecommunications (whether it is POTS, ISDN, wireless, satellite, videoconferencing, VoIP, or other).

For further information, please visit www.medetel.eu.

Most Popular Now

Lilly will supply an additional 150,000 doses of b…

Eli Lilly and Company (NYSE: LLY) announced a modified purchase agreement with the U.S. government to supply an additional 150,000 doses of bebtelovimab for approximately...

Bayer to sell men's health product Nebido™ to Grün…

Bayer and Grünenthal have entered into a definitive agreement regarding the sale of Bayer's men's health product Nebido™ (testosterone undecanoate), for a purchase price ...

Pfizer and BioNTech complete submission to Europea…

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced they have completed a submission to the European Medicines Agency (EMA) for an Omicron-adapted biva...

The fourth COVID-19 vaccine reduces the risk of de…

A new study by Tel Aviv University and Ben Gurion University of the Negev, in collaboration with the Israeli Ministry of Health, has found that the fourth COVID-19 vaccin...

Vaccine protection against COVID-19 short-lived, b…

Since COVID-19 vaccines first became available to protect against infection and severe illness, there has been much uncertainty about how long the protection lasts, and w...

AstraZeneca to acquire TeneoTwo and its clinical-s…

AstraZeneca announced an agreement to acquire TeneoTwo, Inc. (TeneoTwo)i, including its Phase I clinical-stage CD19/CD3 T-cell engager, TNB-486, currently under evaluatio...

Demonstration of a potent, universal coronavirus m…

The SARS-CoV-2 that causes COVID-19 has killed 6.3 million people worldwide since 2019, painfully highlighting the vulnerability of humanity to novel coronaviruses. Re...

Research shows investigational drug fosters nerve …

Scientists from the University of Birmingham have shown that a brain-penetrating candidate drug currently in development as a cancer therapy can foster regeneration of da...

NIH launches clinical trial of mRNA Nipah virus va…

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has launched an early-stage clinical trial evaluating an inv...

Anti-inflammatory compound shows potential in trea…

An anti-inflammatory compound may have the potential to treat systemic inflammation and brain injury in patients with severe COVID-19 and significantly reduce their chanc...

Vaccine-induced immune response to omicron wanes s…

Although COVID-19 booster vaccinations in adults elicit high levels of neutralizing antibodies against the Omicron variant of SARS-CoV-2, antibody levels decrease substan...

SARS-CoV-2 hijacks nanotubes between neurons to in…

COVID-19 often leads to neurological symptoms, such as a loss of taste or smell, or cognitive impairments (including memory loss and concentration difficulties), both dur...